Current position

Ray Dalio’s Cardinal Health Inc (CAH) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2006Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares782.04KHighest verified quarter-end share count
Quarters reported59Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Cardinal Health Inc in Q2 2006. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 132.08K shares. The latest verified filing showed: Bought 14.6% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 14.6% more+16.85K shares · 132.08K shares reported after the change
Filing context

Quarter-end price $237.56 · Estimated holding basis $157.91

Q1 2026
Sold 46.8% of the position−101.44K shares · 115.23K shares remained
Filing context

Quarter-end price $211.31 · Estimated holding basis $146.27

Q4 2025
Sold 20.4% of the position−55.36K shares · 216.67K shares remained
Filing context

Quarter-end price $205.50 · Estimated holding basis $146.27

Q3 2025
Bought 5.1% more+13.28K shares · 272.03K shares reported after the change
Filing context

Quarter-end price $156.96 · Estimated holding basis $146.27

Q2 2025
Bought 258.0% more+186.47K shares · 258.76K shares reported after the change
Filing context

Quarter-end price $168.00 · Estimated holding basis $145.72

Q1 2025
Sold 82.3% of the position−336.47K shares · 72.28K shares remained
Filing context

Quarter-end price $137.77 · Estimated holding basis $88.23

Portfolio importance

How important is Cardinal Health Inc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#130of 997 reported positions
Peak portfolio weight0.4%Q2 2018
Best historical rank#22Q4 2017
At peak importanceQ2 2018
CAH
0.4%
Largest holding
22.7%
Cross-investor discovery

Who else owns Cardinal Health Inc?

Also reported by 1 other tracked investor in their latest verified filings.

Joel GreenblattGotham Asset Management
CAH0.1% of reported portfolio
Explore Cardinal Health Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$234.892026-09-14

Market context only; not an investor transaction price.

Latest filing quarter-end price$237.56Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$157.91Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.